MEGHAN GUTIERREZ — Lobbyist Profile | Poliscope

MEGHAN GUTIERREZ

Reported covered position: N/A

Filings

Clients

Firms

Years active

2008–2021

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
LYMPHOMA RESEARCH FOUNDATION	30	2008–2021

Lobbying firms

Firm	Filings	Years
LYMPHOMA RESEARCH FOUNDATION	30	2008–2021

Bills explicitly cited in this lobbyist’s assigned issues (3)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 2739

Cancer Drug Coverage Parity Act of 2015

Client: LYMPHOMA RESEARCH FOUNDATION · Firm: LYMPHOMA RESEARCH FOUNDATION

Open original LDA filing ↗

Cited source text

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program

S. 1566

Cancer Drug Coverage Parity Act of 2015

Client: LYMPHOMA RESEARCH FOUNDATION · Firm: LYMPHOMA RESEARCH FOUNDATION

Open original LDA filing ↗

Cited source text

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program

Original LDA source filings (30)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2021 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Cancer Survivorship COIVD-19 Support for People with Blood Cancer Cancer Care

Filing targets: HOUSE OF REPRESENTATIVES

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2020 · first_quarter · 1A

Firm income: —Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 26 more original filings

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2016 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2014 · fourth_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Healthcare

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2013 · third_quarter · Q3

Firm income: —Client expense: $7,526Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Oral Chemotherapy Parity Legislation Appropriations: Department of Defense Congressionally Directed Medical Research Programs

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2013 · fourth_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

NIH/ NCI/ DoD Biomedical Research Funding Healthcare Issues

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2013 · second_quarter · Q2

Firm income: —Client expense: $6,496Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Oral Chemotherapy Parity Drug Distribution Security

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2013 · first_quarter · Q1

Firm income: —Client expense: $6,317Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Oral Chemotherapy Parity Cancer Research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2012 · second_quarter · Q2

Firm income: —Client expense: $8,738Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Prescription Drug Shortages Oral Chemotherapy Parity

BUD

Budget/Appropriations

FY 2013 Labor-HHS-Education Appropriations: Blood Cancer Education Programs

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2012 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

FY 2013 Department of Defense Appropriations: Congressionally Directed Medical Research Program, Blood Cancer Research

HCR

Health Issues

Blood Cancer Education Programming Oral Chemotherapy Parity

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2011 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2012 Department of Defense Appropriations: Congressionally Directed Medical Research Program, Blood Cancer Research FY 2012 Labor-HHS-Education Appropriations: Centers for Disease Control and Prevention, Ferraro Cancer Education Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2011 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2011 · second_quarter · Q2

Firm income: —Client expense: $8,405Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2011 · first_quarter · Q1

Firm income: —Client expense: $7,853Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2011 Department of Defense Appropriations: Congressionally Directed Medical Research Program, Blood Cancer Research FY 2011 Labor-HHS-Education Appropriations: Centers for Disease Control and Prevention, Ferraro Cancer Education Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2010 · fourth_quarter · Q4

Firm income: —Client expense: $7,678Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2010 · third_quarter · Q3

Firm income: —Client expense: $8,363Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

HCR

Health Issues

Blood Cancer Resolution

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2010 · second_quarter · Q2

Firm income: —Client expense: $8,824Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2010 · first_quarter · Q1

Firm income: —Client expense: $8,226Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2010 · first_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Cancer research and health care.

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2009 · fourth_quarter · Q4

Firm income: —Client expense: $8,426Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2010 Defense Appropriations: Blood Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2009 · fourth_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Cancer research and health care.

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2009 · third_quarter · Q3

Firm income: —Client expense: $8,466Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2010 Defense Appropriations: Blood Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2009 · second_quarter · Q2

Firm income: —Client expense: $14,822Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2010 Defense Appropriations: Blood Cancer Research Program NIH/ NCI Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2009 · first_quarter · Q1

Firm income: —Client expense: $18,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2010 Defense Appropriations: Blood Cancer Research Program NIH/NCI Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2008 · fourth_quarter · Q4

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

BUD

Budget/Appropriations

FY 2009 Defense Appropriations: Blood Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2008 · third_quarter · Q3

Firm income: —Client expense: $8,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MMM

Medicare/Medicaid

Medicare reimbursement for radioimmunotherapy (lymphoma)

BUD

Budget/Appropriations

FY 2009 Defense Appropriations: Blood Cancer Research Program (H.R. 2638)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2008 · second_quarter · Q2

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

FY 2009 Defense Appropriations: Blood Cancer Research Program

MMM

Medicare/Medicaid

Medicare reimbursement for radioimmunotherapy (lymphoma)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

LYMPHOMA RESEARCH FOUNDATION via LYMPHOMA RESEARCH FOUNDATION

2008 · first_quarter · Q1

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

FY 2009 Department of Defense Appropriations: Blood Cancer Research Program

MMM

Medicare/Medicaid

Medicare reimbursement for radioimmunotherapy treatment (lymphoma)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE